Diabetes Research and Clinical Practice
Volume 57, Issue 1 , Pages 61-69 , July 2002

Influence of type 2 diabetes mellitus on cardiovascular disease mortality: findings from the Hawaii–Los Angeles–Hiroshima study

  • Michinori Imazu

      Affiliations

    • Second Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima-city 734-8551, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-82-257-5196; fax: +81-82-255-7360
    • ,
  • Kotaro Sumii

      Affiliations

    • Second Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima-city 734-8551, Japan
    • ,
  • Hideya Yamamoto

      Affiliations

    • Second Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima-city 734-8551, Japan
    • ,
  • Mamoru Toyofuku

      Affiliations

    • Second Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima-city 734-8551, Japan
    • ,
  • Futoshi Tadehara

      Affiliations

    • Second Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima-city 734-8551, Japan
    • ,
  • Masamichi Okubo

      Affiliations

    • Second Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima-city 734-8551, Japan
    • ,
  • Michio Yamakido

      Affiliations

    • Second Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima-city 734-8551, Japan
    • ,
  • Nobuoki Kohno

      Affiliations

    • Second Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima-city 734-8551, Japan
    • ,
  • Alvin T. Onaka

      Affiliations

    • Department of Health, State of Hawaii, USA

Received 23 April 2001 ,Revised 7 January 2002 ,Accepted 24 January 2002.

References 

  1. Kannel WB, McGee DL. Diabetes and cardiovascular disease, the Framingham study. J. Am. Med. Assoc. 1979;241:2035–2038
  2. Butler WJ, Ostrander LD, Carman WJ, Lamphiear DE. Mortality from coronary heart disease in the Tecumseh study. Long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am. J. Epidemiol. 1985;121:541–547
  3. Pan WH, Cedres LB, Liu K, et al.  Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am. J. Epidemiol. 1986;123:504–516
  4. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am. J. Epidemiol. 1988;128:389–401
  5. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994;43:960–967
  6. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16:434–444
  7. Kawate R, Yamakido M, Nishimoto Y, Bennett PH, Hamman RF, Knowler WC. Diabetes mellitus and its vascular complications in Japanese migrants on the Island of Hawaii. Diabetes Care. 1979;2:161–170
  8. Hara H, Egusa G, Yamakido M, Kawate R. The high prevalence of diabetes mellitus and hyperinsulinemia among the Japanese–Americans living in Hawaii and Los Angeles. Diabetes Res. Clin. Pract. 1994;24(Suppl.):S37–S42
  9. Fischl J, Federman D, Talmor N. Preparation of a modified glucose oxidase reagent for the polarographic determination of glucose with the Beckman ‘glucose analyzer’. Clin. Chem. 1975;21:760–761
  10. Henry RJ, Cannon DC, Winkleman JW. In: Clinical Chemistry, Principles and Techniques. second ed.. Harper & Row; 1974;p. 1058
  11. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120–126
  12. Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham study. Am. Heart J. 1985;110:1100–1107
  13. Howard BV. Lipoprotein metabolism in diabetes mellitus. J. Lipid Res. 1987;28:613–628
  14. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. Five-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation. 1990;82:27–36
  15. Wingard DL, Barrett-Connor E, Criqui MH, Suarez L. Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am. J. Epidemiol. 1983;117:19–26
  16. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. J. Am. Med. Assoc. 1991;265:627–631
  17. Laakso M, Ronnemaa T, Lehto S, Puukka P, Kallio V, Pyörälaä K. Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?. Diabetologia. 1995;38:487–493
  18. Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. New Engl. J. Med. 1984;311:953–959
  19. Wingard DL, Barrett-Connor E. Family history of diabetes and cardiovascular disease risk factors and mortality among euglycemic, borderline hyperglycemic, and diabetic adults. Am. J. Epidemiol. 1987;125:948–958
  20. Gall MA, Rossing P, Skott P, et al.  Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991;34:655–661
  21. Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of HbAlc with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes. 1992;41:202–208
  22. Laakso M, Lehto S, Penttı̈lä I, Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation. 1993;88:1421–1430
  23. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993;36:1175–1184
  24. Andersson DK, Svärdsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care. 1995;18:1534–1543
  25. Bjømholt JV, Erikssen G, Aaser E, et al.  Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care. 1999;22:45–49
  26. UK Prospective Diabetes Study Group. Intensive blood–glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  27. Stout RW. Insulin and atheroma. Twenty-year perspective. Diabetes Care. 1990;13:631–654
  28. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131–141
  29. Welbom TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154–160
  30. Eschwège E, Richard JL, Thibult N, et al.  Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris prospective study, 10 years later. Horm. Metab. Res. 1985;15(Suppl.):41–46
  31. Després JP, Lamarche B, Mauriege P, et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. New Engl. J. Med. 1996;334:952–957
  32. Welin L, Eriksson H, Larsson B, Ohlson LO, Svärdsudd K, Tibblin G. Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia. 1992;35:766–770
  33. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984–1991. Am. J. Epidemiol. 1994;140:857–869
  34. Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97:996–1001

PII: S0168-8227(02)00016-5

Diabetes Research and Clinical Practice
Volume 57, Issue 1 , Pages 61-69 , July 2002

Article Tools